SI2080516T1 - Uporaba iztiocianatnih derivatov kot sredstev proti mielomu - Google Patents

Uporaba iztiocianatnih derivatov kot sredstev proti mielomu

Info

Publication number
SI2080516T1
SI2080516T1 SI200830332T SI200830332T SI2080516T1 SI 2080516 T1 SI2080516 T1 SI 2080516T1 SI 200830332 T SI200830332 T SI 200830332T SI 200830332 T SI200830332 T SI 200830332T SI 2080516 T1 SI2080516 T1 SI 2080516T1
Authority
SI
Slovenia
Prior art keywords
isothiocyanate derivatives
myeloma
myeloma agents
agents
isothiocyanate
Prior art date
Application number
SI200830332T
Other languages
English (en)
Inventor
Paolo Morazzoni
Carla Manzotti
Gabriele Fontana
Antonella Riva
Renato Iori
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena Spa filed Critical Indena Spa
Publication of SI2080516T1 publication Critical patent/SI2080516T1/sl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/31Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/26Cyanate or isocyanate esters; Thiocyanate or isothiocyanate esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024Esters of saccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
SI200830332T 2008-01-18 2008-01-18 Uporaba iztiocianatnih derivatov kot sredstev proti mielomu SI2080516T1 (sl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP08100658A EP2080516B1 (en) 2008-01-18 2008-01-18 Use of isothiocyanate derivatives as anti-myeloma agents

Publications (1)

Publication Number Publication Date
SI2080516T1 true SI2080516T1 (sl) 2011-09-30

Family

ID=39247811

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200830332T SI2080516T1 (sl) 2008-01-18 2008-01-18 Uporaba iztiocianatnih derivatov kot sredstev proti mielomu

Country Status (17)

Country Link
US (1) US8772251B2 (sl)
EP (1) EP2080516B1 (sl)
JP (1) JP5386507B2 (sl)
KR (1) KR101523042B1 (sl)
CN (1) CN101918006B (sl)
AT (1) ATE511845T1 (sl)
AU (1) AU2008347390B2 (sl)
CA (1) CA2712258C (sl)
DK (1) DK2080516T3 (sl)
ES (1) ES2363385T3 (sl)
HR (1) HRP20110451T1 (sl)
IL (1) IL207011A (sl)
PL (1) PL2080516T3 (sl)
PT (1) PT2080516E (sl)
RU (1) RU2480217C2 (sl)
SI (1) SI2080516T1 (sl)
WO (1) WO2009089889A1 (sl)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10308599B2 (en) 2011-01-03 2019-06-04 The William M. Yarbrough Foundation Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use
US10647668B2 (en) 2011-01-03 2020-05-12 The William M. Yarbrough Foundation Isothiocyanate functional surfactant and associated method of use
US8933119B2 (en) 2011-01-03 2015-01-13 The William M. Yarbrough Foundation Method for treating phytophotodermatitis
US10273205B2 (en) 2011-01-03 2019-04-30 The William M. Yarbrough Foundation Isothiocyanate functional surfactants, formulations incorporating isothiocyanate functional surfactants and associated methods for treating biofilms
US11279674B2 (en) 2011-01-03 2022-03-22 The William M. Yarbrough Foundation Isothiocyanate functional surfactant and associated method of use
US9962361B2 (en) 2011-01-03 2018-05-08 The William M. Yarbrough Foundation Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use
US10640464B2 (en) 2011-01-03 2020-05-05 The William M. Yarbrough Foundation Use of isothiocyanate functional surfactants as Nrf2 inducers to treat epidermolysis bullosa simplex and related diseases
US11407713B2 (en) 2011-01-03 2022-08-09 The William M. Yarbrough Foundation Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use
US8865765B2 (en) 2011-01-12 2014-10-21 The William M. Yarbrough Foundation Method for treating eczema
US9532969B2 (en) 2011-02-08 2017-01-03 The William M. Yarbrough Foundation Method for treating psoriasis
RU2014116229A (ru) 2011-09-23 2015-10-27 Даблхил Гмбх Новые соединения изоцианата и изотиоцианата для лечения злокачественных новообразований
US10434081B2 (en) 2012-07-26 2019-10-08 The William M. Yarbrough Foundation Inhibitors of macrophage migration inhibitory factor
US10335387B2 (en) 2012-07-26 2019-07-02 The William M. Yarbrough Foundation Method for treating infectious diseases with isothiocyanate functional compounds
US9949943B2 (en) 2012-07-26 2018-04-24 The William M. Yarbrough Foundation Method for treating neurodegenerative diseases
US10080734B2 (en) 2012-07-26 2018-09-25 The William M. Yarbrough Foundation Method for treating autism and other neurodevelopmental disorders
WO2014018874A1 (en) 2012-07-26 2014-01-30 The William M. Yarbrough Foundation Method for treating skin cancer
US10441561B2 (en) 2012-07-26 2019-10-15 The William M. Yanbrough Foundation Method for treating benign prostatic hyperplasia (BPH), prostatitis, and prostate cancer
US10434082B2 (en) 2012-07-26 2019-10-08 The William M. Yarbrough Foundation Isothiocyanate functional compounds augmented with secondary antineoplastic medicaments and associated methods for treating neoplasms
US9839621B2 (en) 2012-07-26 2017-12-12 The William M. Yarbrough Foundation Method for treating bladder cancer
CN103262850B (zh) * 2013-01-16 2014-06-11 长沙理工大学 一种石蒜生长促进剂及其使用方法
EP2974726A4 (en) * 2013-03-14 2017-01-04 Tiacen Ltd Agent for the prophylaxis and/or treatment of neoplastic diseases
AU2014342214B2 (en) * 2013-11-01 2020-05-21 Rutgers, The State University Of New Jersey Extracts from plants of the Moringaceae family and methods of making
EP3078371A1 (en) * 2015-04-10 2016-10-12 INDENA S.p.A. Use of isothiocyanate derivatives as modulators of peripheral and neuropathic pain
CN107857781A (zh) * 2017-11-16 2018-03-30 云南农业大学 一种从辣木籽中制备4‑α‑L‑鼠李糖基‑异硫氰酸苄酯的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001283462A1 (en) * 2000-08-21 2002-03-04 Jed W. Fahey Treatment of helicobacter with isothiocyanates
US6988664B1 (en) * 2004-09-30 2006-01-24 Symbol Technologies, Inc. Removable cover for an electronic device
US20060127996A1 (en) * 2004-12-14 2006-06-15 Johns Hopkins University Method of extraction of isothiocyanates into oil from glucosinolate-containing plants and method of producing products with oil containing isothiocyanates extracted from glucosinolate-containing plants

Also Published As

Publication number Publication date
IL207011A0 (en) 2010-12-30
KR20100102660A (ko) 2010-09-24
JP2011509955A (ja) 2011-03-31
US8772251B2 (en) 2014-07-08
KR101523042B1 (ko) 2015-05-26
WO2009089889A1 (en) 2009-07-23
US20110053870A1 (en) 2011-03-03
CA2712258A1 (en) 2009-07-23
CN101918006A (zh) 2010-12-15
DK2080516T3 (da) 2011-07-11
CN101918006B (zh) 2012-11-21
CA2712258C (en) 2013-12-10
PT2080516E (pt) 2011-07-01
RU2480217C2 (ru) 2013-04-27
JP5386507B2 (ja) 2014-01-15
EP2080516B1 (en) 2011-06-08
AU2008347390B2 (en) 2014-03-13
AU2008347390A1 (en) 2009-07-23
IL207011A (en) 2014-04-30
HRP20110451T1 (hr) 2011-07-31
EP2080516A1 (en) 2009-07-22
RU2010129238A (ru) 2012-01-20
ES2363385T3 (es) 2011-08-02
ATE511845T1 (de) 2011-06-15
PL2080516T3 (pl) 2011-12-30

Similar Documents

Publication Publication Date Title
IL207011A0 (en) Use of isothiocyanate derivatives as anti-myeloma agents
HUS1800011I1 (hu) Kombinációs terápia szubsztituált oxazolidinonokkal
PL2001892T3 (pl) Imidazolotiazolowe związki do leczenia chorób proliferacyjnych
WO2009051670A3 (en) Oxylipin compounds for the treatment of ophthalmic conditions
IL200862A0 (en) 3-imidazolyl-indoles for the treatment of proliferative diseases
DOP2011000399A (es) Derivados de imidazolidin-2-ona 1,3-disustituida como inhibidores de cyp17
HK1144390A1 (en) Compositions for the treatment of neoplastic diseases
ZA201105720B (en) Compounds for the treatment of hepatitis c
ZA200906129B (en) Compounds for the treatment of hepatitis c
SI2024368T1 (sl) Derivati 6,7,8,9-tetrahidro-5h-pirimido(4,5-d)azepin-4-il)-amina kot modulatorji trpv 1 za zdravljenje boleäśine
IL211313A0 (en) Compounds, compositions and methods for the treatment of ??-amyloid diseases and synucleinopathies
IL208357A0 (en) Spiro-indole derivatives for the treatment of parasitic diseases
SI2209784T1 (sl) Spojine za zdravljenje hepatitisa C
ZA201000923B (en) Compounds for the treatment of hepatitis c
MY160392A (en) Triptolide prodrugs
FI20095600A (fi) Koostumus ihosairauksien hoitoa varten
GB0715790D0 (en) Drug combination for the treatment of sialorrhoea
IL211189A0 (en) Compounds for the treatment of peripheral neuropathies
EP2328877A4 (en) 1,4-BENZOXAZINE COMPOUNDS AND DERIVATIVES THEREOF AS THERAPEUTIC MEDICINES FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS
MX2010001303A (es) Compuestos terapeuticos.
DE602008002598D1 (en) Cyclohexylderivate
EP2183256A4 (en) THERAPEUTIC COMPOUNDS
EP2271328A4 (en) ANTISEPTIC COMPOSITIONS FOR THE TREATMENT OF INFECTIONS
EP2578588A4 (en) NEW DERIVATIVES OF 1, 4 -DIAZEPINES, PDE-5 INHIBITORS
GB0604772D0 (en) Use of substituted amine compounds for the treatment of food related disorders